|Videos|March 12, 2022

Augmenting corneal thickness with FDA-approved hypotonic riboflavin

Author(s)Alex Delaney-Gesing, Senior Editor

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.

See more conference coverage

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related Content

Takeaways from this week in optometry | Image Credit: Canva

Takeaways from this week in optometry: August 10-August 14

August 15th 2026

Patient speaking with physician Image credit: AdobeStock/LuneVA/peopleimages.com

Artelo Biosciences enrolls first patient in phase 2 DREAM study in patients with glaucoma

ByMartin David Harp, Editor, Ophthalmology Times

August 14th 2026

Patient correspondence | Image Credit: Adobe Stock/StockPhotoPro

Study finds that current ophthalmic patient letters may pose comprehension difficulty

August 13th 2026

Contact lens closeup Image credit: Canva

WaveDȳn integrates with Bausch + Lomb and WAVE for scleral lens fitting

ByJordana Joy, Editor

August 12th 2026

Lindsay Elkins, OD, FAAO, discusses volunteering with Remote Area Medical (RAM) to provide free eye care at pop-up clinics

Remote Area Medical: Lindsay Elkins, OD, FAAO, on care for underserved communities

ByLindsay Elkins, OD, FAAO,Abigail Lewis, Content Intern

August 11th 2026

Latest CME

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

Judy E. Kim, MD, FARVO, FASRS; Anat Loewenstein, MD, MHA; Deepak Sambhara, MD, FASRS

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

In-Person + Virtual Event

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

September 13, 2026

EyeCon 2026

EyeCon 2026

September 26, 2026

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Takeaways from this week in optometry: August 10-August 14

WaveDȳn integrates with Bausch + Lomb and WAVE for scleral lens fitting

Remote Area Medical: Lindsay Elkins, OD, FAAO, on care for underserved communities

Study finds that current ophthalmic patient letters may pose comprehension difficulty

Artelo Biosciences enrolls first patient in phase 2 DREAM study in patients with glaucoma